Clinical Trials of Texas, Inc

Summary

Clinical Trials of Texas, Inc is a medical facility located in San Antonio, Texas. This center is recognized for care of Healthy Subjects, Type 2 Diabetes, Diabetes, Nonalcoholic Steatohepatitis, Non-alcoholic Fatty Liver Disease and other specialties. Clinical Trials of Texas, Inc is involved with conducting 301 clinical trials across 373 conditions. There are 4 research doctors associated with this hospital, such as Pendleton Wickersham, MD, Douglas Scott Denham, Daniel Peterson, MD, and Alan Hand, MD.

Top PIs

Clinical Trials running at Clinical Trials of Texas, Inc

Atherosclerosis

Cardiovascular Disease

Liver Cancer

Liver Fibrosis

Hyperlipidemia

Fatty Liver Disease

Obesity

Prader-Willi Syndrome

Cerebral Amyloid Angiopathy

Lupus

Pelacarsen

for Cardiovascular Disease

This non-randomized, rollover extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed either of the double-blind parent studies (CTQJ230A12303 or CTQJ230A12304).

Recruiting

2 awards

Phase 3

Lepodisiran

for Cardiovascular Disease

This trial is testing lepodisiran, a medication given as an injection under the skin. It targets people with high levels of lipoprotein(a) who have cardiovascular disease or are at risk of heart attack or stroke. The medication works by lowering lipoprotein(a) levels to reduce the risk of these cardiovascular events.

Recruiting

1 award

Phase 3

DII235

for High Cholesterol

The main purpose of this study is to determine the safety and efficacy of DII235 in adults with elevated lipoprotein(a).

Recruiting

0 awards

Phase 2

2 criteria